Viracta Therapeutics SG&A Expense (TTM) Insights

Viracta Therapeutics Inc (VIRX)

0.551 -0.03 (-4.67%) USD | NASDAQ | Jun 28, 16:00

0.569 +0.02 (+3.27%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
March 31, 2024	16.64M
December 31, 2023	17.32M
September 30, 2023	18.04M
June 30, 2023	24.66M
March 31, 2023	24.59M
December 31, 2022	24.33M
September 30, 2022	23.47M

Date	Value
June 30, 2022	16.24M
March 31, 2022	15.93M
December 31, 2021	15.44M
September 30, 2021	13.99M
June 30, 2021	11.17M
March 31, 2021	8.177M
December 31, 2020	5.348M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

5.348M

Minimum

Dec 2020

24.66M

Maximum

Jun 2023

16.81M

Average

16.44M

Median

SG&A Expense (TTM) Benchmarks